D
Grant

DoW Pancreatic Cancer Research Program, Focused Pilot Award

Nationwide

About

Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Focused Pilot Award supports the exploration and development of impactful and innovative concepts under a patient-centered focus area of pancreatic cancer research that could ultimately lead to major advancements that will have a profound effect on patients’ overall quality of life. The research this award supports should strive to produce robust preliminary data that can serve as a foundation for future clinical or real-world research application. Distinctive Features: This award mechanism allows, but does not require, preliminary data. Applications can support clinical research studies; however, this mechanism does not allow clinical trials. Preclinical animal studies do not meet the intent of this mechanism.

The DoW Pancreatic Cancer Research Program (PCARP) Focused Pilot Award supports researchers and research teams dedicated to exploring innovative and impactful pancreatic cancer research concepts with a patient-centered focus. This award is designed for researchers who want to develop preliminary data and evidence that could lead to significant advancements in pancreatic cancer treatment and patient outcomes. The program prioritizes research that addresses real patient needs and has the potential to meaningfully improve quality of life for pancreatic cancer patients. Unlike some research mechanisms, this award allows flexibility in preliminary data requirements, making it accessible to researchers at earlier stages of concept development. Clinical research studies are eligible, though clinical trials are not. The award aims to generate robust preliminary findings that serve as a strong foundation for future clinical applications and real-world research initiatives. Researchers seeking to advance pancreatic cancer science with innovative approaches and patient-centered outcomes should consider applying to this competitive program.

Funding Facts

● Applications open

Deadline

October 7, 2026

Who can apply

Unrestricted (i.e., open to any type of entity above), su...
Apply on Grants.gov

Last verified July 5, 2026 · Source: Grants.gov

Grant Details

Funding Range

Varies by cycle

Deadline

2026-10-07

Grant Type

federal

Application Cycle

Annual (FY2026 deadline: October 7, 2026)

Best For

Pancreatic cancer researchers, clinical research teams, academic institutions, and research organizations seeking to develop innovative patient-centered research concepts

Frequently Asked Questions

Who is eligible for DoW Pancreatic Cancer Research Program, Focused Pilot Award?

Specific eligibility criteria are not provided in the available information. For detailed eligibility requirements, including institutional requirements, researcher qualifications, and other specific criteria, please visit the official Department of Defense or program website for the complete funding announcement.

How much funding does DoW Pancreatic Cancer Research Program, Focused Pilot Award provide?

Funding amounts are not specified in the available information. Award amounts may vary by fiscal year and application quality. Contact the program directly or review the official funding announcement for current funding ranges and budget guidance.

How do I apply for DoW Pancreatic Cancer Research Program, Focused Pilot Award?

Applications are typically submitted through official government funding portals. For FY26, the application deadline is October 7, 2026. Visit the official Department of Defense Pancreatic Cancer Research Program website or the primary funding announcement for specific submission instructions, required documentation, and portal information.

What can DoW Pancreatic Cancer Research Program, Focused Pilot Award funding be used for?

This award supports pancreatic cancer research with a patient-centered focus. Eligible research includes clinical research studies that explore innovative concepts and generate preliminary data. The program does not support preclinical animal studies or clinical trials. Funding should support research that could lead to major advancements in patient quality of life and outcomes.

Last updated: July 5, 2026